VIDAS® TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB
- PMID: 34969431
- PMCID: PMC8734189
- DOI: 10.5588/ijtld.21.0478
VIDAS® TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB
Conflict of interest statement
Conflicts of interest: DG is a consultant of bioMérieux (Marcy l’Etoile, France), Qiagen (Hilden, Germany), and Diasorin and received a grant from Biomerieux. This study was supported by bioMérieux, and the Italian Ministry of Health (Ricerca Corrente-Linea 4).
Figures



References
-
- World Health Organization WHO; 2021. Global Tuberculosis Report 2021.https://www.who.int/publications/i/item/9789240037021
-
- Petruccioli E, et al. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB plus. J Infect. 2016;73:588–597. - PubMed
-
- Chiacchio T, et al. Characterization of QuantiFERON-TB-plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases. J Infect. 2019;79:15–23. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials